SCHEMBL5040593

SCHEMBL5040593

COC(C(=O)O)c1ccc(O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.46
ESR1 P03372 4/20 0.43
ESR2 Q92731 3/20 0.43
PDCD1 Q15116 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
ALDH1A1 P00352 2/20 0.40
GAA P10253 2/20 0.40
RECQL P46063 1/20 0.40
BLM P54132 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TSHR P16473 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9809620 0.84 ESR1 (0.41) SRCESR1ESR2PDCD1CD274
SCHEMBL24327745 0.83 KEAP1 (0.55) KEAP1NFE2L2ALDH1A1GAANPSR1
SCHEMBL28194345 0.83 CYP2C9 (0.46) KEAP1NFE2L2ALDH1A1GAACYP2D6
SCHEMBL29069338 0.83 KEAP1 (0.41) KEAP1NFE2L2ALDH1A1GAARECQL
SCHEMBL103235 0.83 ALDH1A1 (0.54) SRCKEAP1NFE2L2ALDH1A1GAA
SCHEMBL104518 0.83 ALDH1A1 (0.54) SRCKEAP1NFE2L2ALDH1A1GAA
SCHEMBL155984 0.83 ALDH1A1 (0.54) SRCKEAP1NFE2L2ALDH1A1GAA
SCHEMBL24327729 0.82 KDM4E (0.46) KEAP1NFE2L2ALDH1A1GAANPSR1
SCHEMBL3578941 0.82 ESR1 (0.54) ESR1ESR2PDCD1CD274CA12
SCHEMBL4280687 0.82 ESR1 (0.42) ESR1ESR2PDCD1CD274CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 SRC 2477/4885ESR1 4141/4885ESR2 4257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.